NHS Western Isles prescribing weight loss drugs at triple the rate of other health boards

• NHS Western Isles prescribes GLP-1 receptor agonists at three times the rate of other Scottish health boards, indicating substantial geographical variation in weight loss drug accessibility across Scotland
• Significant prescribing disparities between health boards suggest inconsistent implementation of national guidelines and potential inequities in patient access to these medications
• Clinicians should be aware of regional variations in GLP-1 availability and consider engaging with local formulary decisions to ensure equitable prescribing practices for eligible patients

A new report finds "significant variation" between Scotland's health boards prescribing new medicines.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.